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Abstract
Structure determination of proteins and enzymes by X-ray crystallography remains the most widely used approach to com-
plement functional and mechanistic studies. Capturing the structures of intact redox states in metalloenzymes is critical for 
assigning the chemistry carried out by the metal in the catalytic cycle. Unfortunately, X-rays interact with protein crystals 
to generate solvated photoelectrons that can reduce redox active metals and hence change the coordination geometry and 
the coupled protein structure. Approaches to mitigate such site-specific radiation damage continue to be developed, but 
nevertheless application of such approaches to metalloenzymes in combination with mechanistic studies are often over-
looked. In this review, we summarize our recent structural and kinetic studies on a set of three heme peroxidases found in 
the bacterium Streptomyces lividans that each belong to the dye decolourizing peroxidase (DyP) superfamily. Kinetically, 
each of these DyPs has a distinct reactivity with hydrogen peroxide. Through a combination of low dose synchrotron X-ray 
crystallography and zero dose serial femtosecond X-ray crystallography using an X-ray free electron laser (XFEL), high-
resolution structures with unambiguous redox state assignment of the ferric and ferryl  (FeIV = O) heme species have been 
obtained. Experiments using stopped-flow kinetics, solvent-isotope exchange and site-directed mutagenesis with this set of 
redox state validated DyP structures have provided the first comprehensive kinetic and structural framework for how DyPs 
can modulate their distal heme pocket Asp/Arg dyad to use either the Asp or the Arg to facilitate proton transfer and rate 
enhancement of peroxide heterolysis.
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Introduction
Dye-decolorizing peroxidases (DyPs; EC 1.11.1.19) are 
the most recently discovered member of the histidine-heme 
ligated peroxidase superfamily [1]. They are widespread in 
bacterial and fungal genomes [2] and represent a distinct 
heme peroxidase structural family that possess a dimeric 
α + β barrel fold (SCOP 3,000,089, InterPro Pfam CL0032) 
capable of binding a single b-type heme [3, 4]. DyPs were 
initially divided into four phylogenetic classes; types A, B, 
C and D [5], with types C and D later found to be one phy-
logenetic class and now referred to as C/D-type. The A- and 
B-types are exclusively found in bacteria whilst the C/D-
types are found in bacteria and fungi [5]. Historically, their 
name derives from the discovery that a C/D-type displayed 
an ability to oxidise recalcitrant anthraquinone and/or azo-
dyes used in the textile industry [1]. However, it has become 
apparent that not all DyPs possess an ability to oxidise these 
redox dyes and thus the initial naming of this family of heme 
peroxidases is in hindsight rather unfortunate [6]. In fact, 
the physiological function of DyPs is almost completely 
unknown, with only a handful of examples illustrating a 
potential role of fungal C/D-types in lignin oxidation [7, 8] 
and in the degradation of an antifungal anthraquinone com-
pound [9]. Bacterial DyPs are also associated with encap-
sulin systems [10–12]. These proteinaceous nanocompart-
ments are assembled into icosahedral hollow capsids by one 
type of shell protein that serve to encapsulate cargo proteins 
[10, 13, 14]. A recent cryo-EM study has revealed that oli-
gomeric DyP assemblies (dodecamers) can pack inside a 
capsid [15].
All DyPs react with hydrogen peroxide to form high-
valent heme species, commonly referred to as ferryl heme 
[16–18], essential for the oxidative chemistry that results in 
electron transfer from substrates. Although their physiologi-
cal substrates remain unknown, many DyPs, in addition to 
reacting with synthetic dyes, display a wide substrate speci-
ficity with artificial electron donors such as ABTS, guaiacol 
and ferrocyanide [19]. The initial ferryl species formed on 
reaction with peroxide is a two-electron oxidised  FeIV-oxo 
derivative carrying a porphyrin π-cation radical and has an 
electronic absorbance spectrum analogous to the Compound 
I species first identified in horse radish peroxidase (HRP) 
[20, 21]. Following the one-electron reduction of the por-
phyrin π-cation radical, a second ferryl species is formed, 
that has spectral properties analogous to HRP Compound 
II [20, 21], with a further one-electron reduction returning 
the heme to the ferric resting state. Concomitant with this 
peroxide-induced cycle is the coproduction of two water 
molecules and oxidised substrates [20–23].
In the well-studied nonmammalian peroxidases such as 
HRP, ascorbate peroxidase (APX) and yeast cytochrome 
c peroxidase (CcP), a His-Arg dyad is present in the distal 
heme pocket (i.e. the ‘face’ of the heme that binds per-
oxide), with the His assigned a catalytic role in facilitat-
ing proton movement involved in Compound I formation 
[24–27]. It is now recognised that the distal pocket His is 
hydrogen bonded (H-bonded) to a water molecule, to cre-
ate a water-His unit that is energetically more favoured for 
moving a proton from the  Oα atom of the  FeIII-O2H2 com-
plex [28], to generate an anionic precursor to Compound 
I referred to as Compound 0  (FeIII-Oα-OβH) [29, 30]. The 
 Hα proton is then transferred from the distal water-His 
unit to the  Oβ atom of Compound 0 to form  FeIII-O-OH2 
that promotes the heterolytic cleavage of the O–O bond to 
form Compound I and the coproduction of a water mol-
ecule [24, 28]. In DyPs, the distal pocket His residue is 
replaced by an Asp, which is part of the GXXDG motif, 
unique to DyP members [3, 31]. Whereas in nonmamma-
lian peroxidases the distal heme Arg is indirectly involved 
in Compound I formation [27, 32], studies on a handful 
of DyPs have provided evidence to indicate that the Arg 
is directly involved, implying a catalytic role as a proton 
acceptor and donor [33–35]. In other DyPs the Asp has 
been reported to act as the acid–base catalyst [3, 36–39]. 
Thus, it has become clear that there is mechanistic vari-
ation in Compound I formation amongst DyPs and the 
question of why Asp or Arg is selected to facilitate proton 
transfer and rate enhancement of O–O fission amongst 
DyP members remains unanswered.
A holistic approach to studying mechanistic 
features of DyP members
In the soil-dwelling Gram-positive bacterium, Streptomyces 
lividans, three DyPs are present. Based on sequence analy-
sis, two are classed as A-types, each possessing a signal 
sequence that locates them in the extracytoplasmic envi-
ronment. The third is a B-type, which from the absence of 
a signal sequence remains located in the cytoplasm. The 
physiological substrates for these S. lividans DyPs remain 
unknown, but one of the A-types (Dye-type peroxidase A; 
DtpA) has been implicated in a copper trafficking path-
way that regulates a morphological development step in 
the life-cycle of S. lividans [40]. Despite the presence of 
multiple DyP encoding genes in many bacterial and fungal 
genomes, only a handful of rather fractured studies enable 
some comparisons of the structural and kinetic properties of 
DyPs from the same organism [41–44]. We have, therefore, 
focused on a holistic approach using the three S. lividans 
DyPs to decipher mechanistic intricacies of Compound I 
formation. This mini review highlights recent structural 
and kinetic approaches taken to investigate these S. lividans 
DyPs and presents a new framework for understanding 
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different mechanisms of Compound I formation adopted by 
DyPs. It also focuses on the need to pay careful attention to 
the often insidious effects of X-ray radiation, used in crystal-
lographic data collection, on the metal site structure, so as 
to avoid misinterpretation and misassignment of structures 
to particular redox states.
Validation of redox state in X‑ray structures 
is essential for deciphering mechanism
With the advent of high brilliance synchrotron radiation 
sources and their high-throughput data collection capabili-
ties, X-ray crystal structure determination of proteins and 
enzymes has become a relatively routine and increasingly 
automated process, with the often high-resolution structures 
obtained used to assist in the interpretation of mechanism. 
It is now recognised that if the appropriate experimental 
safeguards in the collection of X-ray diffraction data have 
not been put in place, there is a danger of a mismatch 
between the determined structures and mechanism [45]. 
This is because the high-intensity X-rays generated at syn-
chrotron sources are partially absorbed by protein crystals, 
all of which have a high water content. Radiolysis of this 
water produces multiple radical species including a large 
number of solvated photoelectrons that can cause not only 
global radiation damage (i.e. degradation of the crystalline 
order and hence diffracting properties of the crystal, which 
to a certain extant can be countered by cryo-cooling the 
crystals to 100 K), but also site-specific radiation damage 
[46–48]. This site-specific radiation damage can, in the case 
of metalloenzymes, reduce redox active metals via solvated 
photoelectrons and hence change the coordination geometry 
and the coupled protein structure. Thus, site-specific radia-
tion damage is a particular concern for the determination of 
heme-Fe redox states in peroxidases [45, 49], with the rest-
ing state  FeIII and high-valent  FeIV species both exquisitely 
susceptible to site-specific radiation damage. Such damage 
can occur at X-ray doses at least three orders of magnitude 
lower than the 20–30 MGy range, which is an acceptable 
absorbed dose limit for global radiation under cryo-cooled 
conditions [50, 51]. The very low doses required for redox 
state changes essentially rule out the effective determina-
tion of non-damaged states from single crystals at either 
cryogenic or room temperature. Lowering the X-ray flux, 
for example by using an in-house diffractometer or a very 
attenuated synchrotron beam would require either a greatly 
increased data collection time (thereby incurring a similar 
dose as using a more intense source for a shorter time) or 
accepting a much lower resolution dataset which may not 
reveal the details of the metal centre environment. There-
fore, to capture intact (i.e. free of radiation-induced dam-
age) or near-intact structural data from radiation-sensitive 
 FeIII and  FeIV heme species using X-ray crystallography, 
two general approaches have been developed (i) low-dose 
composite (i.e. multi-crystal) structures coupled with single 
crystal spectroscopy to validate redox state before and after 
X-ray exposure (near-intact) [35, 39, 52–55] and (ii) the use 
of X-ray free electron lasers (XFELs, zero effective dose) 
[35, 56, 57].
The first DyP X-ray structure was reported in 2007 [3], 
and in the subsequent years over 50 DyP structures have 
been deposited in the Protein Data Bank (PDB). Table 1 pro-
vides a summary of the deposited DyP structures. Except for 
the S. lividans DyP structures, and several recently reported 
structures from the B-type Klebsiella pneumoniae DyP [45], 
none of the deposited DyP structures report a validated 
redox state or mitigating data collection strategies. Pfanzagl 
et al. [45] have reported that an absorbed dose of ~ 40 kGy 
for cryo-cooled heme protein crystals is sufficient to cause 
a 50% reduction of the heme iron redox state independent 
of oxidation state (i.e.  FeIII or  FeIV). Therefore, it can be 
safely assumed, with the exceptions indicated in Table 1, 
that all the DyP structures deposited in the PDB are rep-
resentative of either mixed heme oxidation species or the 
 FeII-heme state. Nevertheless, despite this limitation, many 
of the deposited structures have been used in combination 
with spectroscopic and kinetic data to inform on mechanistic 
features associated with the formation of transient  FeIV-oxo 
intermediates starting from the  FeIII-heme resting state. 
Whilst the overarching mechanistic conclusions may be pre-
dominantly correct, details of subtle local structural changes 
and perturbations to solvent networks in non-validated struc-
tures may be missed, which can have significant bearing for 
a complete mechanistic understanding. This is particularly 
the case for distal pocket water molecules, which up until 
recently have never been discussed in the mechanism of 
Compound I formation in DyPs. Two separate reports on 
X-ray dose-dependent effects on cryo-cooled DyP crystals 
highlight such local changes to (i) side chain positions of 
distal heme pocket residues, including the Asp and (ii) distal 
pocket H-bonded water networks, between the  FeIII-heme 
and  FeII-heme states [45, 49]. These changes are significant 
and would undoubtedly confound mechanism assignment, 
particularly for DtpA [39, 49, 55]. Shrestha et al. [58] have 
compared side chain positions of distal heme pocket residues 
and H-bonding patterns of distal water molecules between 
several B-type DyP X-ray crystal structures (3QNS, 5VJ0 
and 6FKS, Table 1) to rationalise kinetic data for Compound 
I formation from the ferric state. These structures can rea-
sonably be assumed to be in either a mixed  FeIII/FeII-heme 
state or an  FeII-heme state, which in the case of the 6FKS 
structure has subsequently been shown to be the ferrous state 
[45]. Furthermore, previously validated structural work on a 
B-type DyP [35] for which the distal Arg is demonstrated to 
be important for proton movement in Compound I formation 
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Table 1  A summary of the X-ray crystal structures of DyPs deposited in the PDB
Organism Class Mutation PDB code and resolution Comment
Structures where a redox state is validated or a dose reported
Streptomyces lividans A WT 5MJH (1.45 Å), 5MAP 
(1.49 Å) [49]
Oxyferrous forms 
WT 6GZW (1.41 Å) [55] Ferric form (see Table 2)
A (Aa) WT 6TB8 (1.80 Å) [39] Ferric form (see Table 2)
WT 6I43 (1.88 Å) [57] Ferric form (see Table 2)
WT 6I7C (1.88 Å) [64] SFX, ferric form with imidazole bound at 6th heme coordination 
position
WT 8I8P, 6Q3E, 6Q3D, 6I8K, 6I8I, 
6I7Z, 6I8O, 6Q34, 6I8Q, 
6I8E, 6Q31, 6I8J, 6IBN 
(1.70–193 Å) [57]
Ferric dose series (32.8 kGy), serial synchrotron
B WT 6YRC (1.99 Å), 6YRJ (1.85 Å) 
[35]
Ferric form (see Table 2)
WT 6YR4 (1.85 Å), 6YRD (1.75 Å) 
[35]
Ferryl Compound I (see Table 2)
Klebsiella pneumoniae B WT 6RQY, 6RR1, 6RR4, 6RR5, 
6RR6, 6RR8 (1.90 Å) [45]
Ferric dose series (2.15 – 53.6 kGy)
WT 6RPE (1.80 Å), 6RPD (1.52 Å) 
[45]
Ferric with cyanide bound at 6th heme position, doses 2.3 kGy 
and 1590 kGy
Structures where the redox state is not validated and no dose reported
Cellulomonas bogoriensis A WT 6QZO (2.40 Å) [103] A natural substitution of the distal Asp with a Glu
Thermomonospora curvata A WT 5JXU (1.75 Å) [104]
Escherichia coli O157 A WT 3O72 (1.95 Å) [42]
Streptomyces coelicolor A WT 4GT2 (1.80 Å)a A-type homologs with 99% sequence identity to S. lividans
A (Aa) WT 4GRC (2.00 Å)a
Bacillus subtilis A WT 6KMN (2.44 Å) [105] 6KMM has HEPES bound at a surface site
WT 6KMM (1.93 Å) [105]
Thermobifida fusca A WT 5FWV (1.80 Å) [106]
Thermobifida cellulosilytica A WT 4GS1 (1.70 Å)a
Rhodococcus jostii B WT 3QNR (2.25 Å), 3QNS 
(1.40 Å) [43]
Forms a hexamer assembly and possess a C-terminal motif to 
target it to the encapsulin nanocompartment [11]
N246H 3VEF (2.64 Å) [33] 4HOV has manganese bound in a pocket
N246A 3VEE (2.40 Å), 4HOV 
(2.20 Å) [33]
R244L 3VEG (2.35 Å) [33]
D153H 3VED (2.50 Å) [33]
D153A 3VEC (2.60 Å) [33]
Klebsiella pneumoniae B WT 6FKS (1.60 Å) [71]
D143A 6FL2 (1.27 Å) [71]
R232A 6FKT (1.86 Å) [71]
D143A/R232A 6FIY (1.09 Å) [71]
Shewanella oneidensis B WT 2HAG (2.75 Å) [107], 2IIZ 
(2.30 Å) [108]
No heme and heme bound
Bacteroides thetaiotaomicron B WT 2GVK (1.60 Å) [107] No heme; hexamer assembly
Vibrio cholerae B WT 5DE0 (2.24 Å) [109]
Escherichia coli O157 B WT 5GT2 (2.09 Å) [44]
Enterobacter lignolyticus B WT 5VJ0 (1.30 Å) [37]
Streptomyces coelicolor B WT 4GU7 (3.10 Å)a 99% sequence identity to S. lividans
Dictyostelium discoideum B WT 7O9J (1.70 Å) [110]
WT 7O9L (1.85 Å) [110] Cyanide bound to heme iron
WT 7ODZ (1.60 Å) [110] Veratryl alcohol bound on surface
Amycolatopsis sp. C/D WT 4G2C (2.25 Å) [111] Manganese binding pocket
Nostoc sp. C/D D204H 5C2I (1.89 Å) [112] Tetramer assembly formed from Cys224-Cys224 disulfide-linked 
dimers
JBIC Journal of Biological Inorganic Chemistry 
1 3
(discussed further below) is overlooked in the investigator’s 
mechanism [58].s
Approaches used to obtain  FeIII‑heme 
resting state structures of S. lividans DyPs
The starting point for our mechanistic investigations into 
the three S. lividans DyPs has been to obtain intact or near-
intact structures of the resting state  FeIII-heme enzyme. To 
achieve this goal, several X-ray approaches have been suc-
cessfully applied. Figure 1 summarises the strategies that 
have been used and Table 2 the pertinent experimental and 
data processing parameters for the structures determined and 
deposited in the PDB. For  FeIII-DtpA, a single crystal, low-
dose, helical data collection strategy was employed at 100 K 
with the redox state of the DtpA crystal monitored along 
the X-ray exposed pathway using in situ UV–Vis micro-
spectrophotometry [55]. The Q-band region of the electronic 
absorbance spectrum of peroxidases has several prominent 
peaks that allow the  FeIII- and  FeII-heme redox states to be 
readily distinguished (Fig. 1A). Composite crystallographic 
datasets using a multi-crystal strategy at 100 K have been 
collected for DtpAa and DtpB (Table 2) [35, 39], making 
use of in situ microspectrophotometry to monitor the Q-band 
region of the absorbance spectrum with spectra recorded 
pre- and post-X-ray exposure of each crystal (Fig. 1A). This 
allowed the extent of any photoreduction to be assessed and 
crystals with an unacceptably high level of reduction to be 
excluded from the final composite dataset. For both the heli-
cal and composite datasets, the absorbed dose was in the low 
tens of kGy range, with the respective values reported in 
Table 2. It is noted that reported doses in Table 2 are all 
less than the typical 40 kGy limit determined to induce 50% 
reduction of  FeIII-heme [45], but are nevertheless sufficient 
to cause site-specific radiation damage. However, in com-
bination with the comparison of the before and after micro-
spectrophotometry data, the structures can be considered 
as near-intact resting state  FeIII-heme. Notably, exposure to 
higher doses resulted in clear reduction of the crystals, lead-
ing to spectral properties consistent with the ferrous form. 
To eliminate site-specific radiation damage, femtosecond-
duration pulses from an XFEL source can be used, which 
allow the collection of diffraction patterns before the onset 
of radiation damage [59–63]. While the X-ray dose is tre-
mendously high in such experiments, the extremely short 
duration of the pulses means that there is insufficient time 
under typical experimental conditions (pulse durations 
of ~ 10 fs or less) for any radiation damage to be manifest in 
the observed structure. This principle is termed ‘diffraction-
before-destruction’ [59], with the approach called serial fem-
tosecond crystallography (SFX) and requires the presenta-
tion of a new crystal for each pulse. Thus, to obtain a protein 
structure using SFX, thousands of single-crystal diffraction 
a No associated publication
Table 1  (continued)
Organism Class Mutation PDB code and resolution Comment
Bjerkandera adusta C/D WT 2D3Q (2.80 Å) [3], 3AFV 
(1.40 Å) [113]
2D3Q first crystal structure of a DyP
WT 3MM2 (1.45 Å) [113] Cyanide bound to heme
WT 3VXI (1.50 Å)a Ascorbate bound at a surface site
WT 3VXJ (1.39 Å)a 2,6-dimethoxyphenol bound at a surface site
D171N 3MM1 (1.42 Å), 3MM3 
(1.40 Å) [113]
Cyanide bound to heme iron in 3MM3
Auricularia auricula-judae C/D WT 4AU9 (2.10 Å) [114], 4W7J 
(1.79 Å) [115]
5AG1 has a δ-meso-nitrated heme
WT 5AG1 (1.85 Å)a
WT 5AG0 (1.75 Å)a
WT 4UZI (2.20 Å) [116] 4UZI has imidazole at the 6th heme coordination position and 
HEPES bound at a surface siteY47S 4W7K (1.05 Å) [115]
D168N 4W7L (1.05 Å) [115]
W377S 4W7M (1.15 Å) [115]
Y147S/W377S 4W7N (1.40 Å) [115]
Y147S/G169L/W377S 4W7O (1.20 Å) [115]
F359G 5IKD (1.11 Å) [117] 5IKD highly stereoselective in oxidising phenyl-sulides 
(S-enantiomer)
5IKG mixed S- and R-enantiomers
L357G 5IKG (1.95 Å) [117]
Pleurotus ostreatus C/D F194Y 6FSK (1. 56 Å) [118] 6FSK MES bound to a surface site; possess a non-canonical 
manganese binding siteF194W 6FSL (2.50 Å)a
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Table 2  Summary of strategies used to determine the redox state validated X-ray structures of S. lividans DyPs along with selected experimental 
and data processing parameters
a number of indexed images used, the number of crystals will be less
FeIII-DtpA FeIII-DtpAa FeIII-DtpAa FeIII-DtpB FeIII-DtpB FeIV-DtpB FeIV-DtpB
X-ray source ESRF SLS SACLA SLS SACLA SLS SACLA
Temperature (K) 100 100 298 100 298 100 298
Number of 
crystals
1 13 72,615a 21 26,223 13 57,909







SFX, pulse length 
10 fs, repetition 














SFX, pulse length 
10 fs, repetition 




Yes Yes No Yes No Yes No
Effective dose 
(kGy)
12.0 17.0–21.7 0 11.4 0 11.3 0
Space group P21 P21 P21 P212121 P212121 P212121 P212121
Unit cell dimen-
sions (Å)
a = 60.1, 
b = 71.0, 
c = 78.1
a = 71.4, b = 67.6, 
c = 72.9
a = 72.7, b = 68.2, 
c = 74.6
a = 85.8, 
b = 120.3, 
c = 196.0
a = 86.7, 
b = 121.6,
c = 199.0
a = 85.4, 
b = 119.9, 
c = 194.2
a = 86.3, b = 121.1, 
c = 198.5
Resolution (Å) 1.41 1.80 1.88 1.99 1.85 1.85 1.75
PDB identifier 6GZW 6TB8 6I43 6YRC 6YRJ 6YR4 6YRD
Fig. 1  Approaches used to obtain low-dose (A) or zero-dose (B) 
X-ray crystal structures of the S. lividans DyPs reported in Table 2. 
In (A) composite synchrotron X-ray data are collected using multiple 
cryo-cooled crystals with microspectrophotometry used to monitor 
the heme oxidation state. B The chip delivery system for SFX crystal-
lography using microcrystals at room temperature
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patterns must be collected from microcrystals (≤ 50 μm) 
efficiently presented to the X-ray beam. An approach that 
we have found successful for determining zero dose struc-
tures of DyPs is the use of silicon fixed-target chips contain-
ing 25,600 apertures that are used to trap the microcrystals 
which are applied in suspensions of between 100 and 200 μl 
(Fig. 1B) [35, 57, 64]. The chips are translated within the 
interval between XFEL pulses stopping at the centre of each 
aperture allowing for the crystal to be exposed only once to 
the X-ray pulse, before moving to the next position during 
the pulse interval (Fig. 1B). An advantage of this and other 
serial delivery systems is that the SFX data can be collected 
at room temperature and, therefore, affords the opportunity 
to acquire structures and observe chemistries that are not 
frozen out, which can be the case with data collection at 
100 K [65]. Using this chip-based SFX approach we have 
been able to determine zero dose structures of DtpAa and 
DtpB in which the  FeIII-heme state is considered pristine 
(Table 2) [35, 57].
Tertiary structure comparison of the three S. 
lividans DyPs
A comparison of the tertiary structures of the three S. liv-
idans DyPs determined using the X-ray approaches sum-
marised in Table 2 are depicted in Fig. 2. The structural 
homology of the dimeric α + β barrel fold is conserved, with 
changes in helical content and loop insertions/deletions con-
tributing to the variation in structural shape and molecular 
weight (Fig. 2). In all cases the b-type heme is located in 
the C-terminal domain with the heme-Fe participating in 
proximal coordination via the  Nδ atom of a His residue. The 
 Nε atom of the proximal His ligand is H-bonded to the  Oδ2 
atom of a conserved Asp, an interaction that imparts signifi-
cant imidazolate character in His-heme ligated peroxidases 
resulting in increased electron-donating ability [23].
Distinct distal heme pocket sites 
in the resting state structures of the S. 
lividans DyPs
By determining the pristine and near-intact heme-FeIII struc-
tures for each S. lividans DyP, a true comparison of the distal 
heme environment, where the chemistry with peroxide takes 
place, is now possible [35, 39, 55, 57].
DtpA and DtpAa
For the two A-type enzymes, the distal heme pocket is 
dominated by a well-ordered network of H-bonded water 
molecules (crystallographic B-factors range between 10 and 
20 Å2) that enable communication between the heme-FeIII 
and the distal Asp/Arg dyad (Fig. 3) [39, 55]. It is important 
to note that the stereochemistry of the DtpAa heme-FeIII 
environment is identical between the composite 100 K struc-
ture and the XFEL room temperature structure, including the 
positions of the H-bonded water molecules [39, 57]. This 
indicates that despite the overall absorbed dose for the 100 K 
structure (Table 2) the approach of using composite datasets 
from multiple low-dose wedges and microspectrophotometry 
nullifies significant specific radiation damage as evidenced 
Fig. 2  Tertiary structures of the three S. lividans DyPs in their 
 FeIII-heme redox state determined using X-ray methods at 100 K as 
outlined in Table 2. One of the α + β barrel fold in each structure is 
highlighted in orange (α) and yellow (β) with the heme shown in 
sticks. PDB codes used are 6G2W (DtpA); 6TB8 (DtpAa); 6YRC 
(DtpB)
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from comparison with the zero dose XFEL structure [39, 
57].
In both the A-type structures a water molecule is found 
close enough to the heme-FeIII for a bonding interaction to 
take place and thus the heme is considered to exist in a hexa-
coordinate state (Fig. 3) [39, 55, 57]. The electronic absorp-
tion (solution and crystal) and EPR spectra are consistent 
with a high-spin ferric heme, and thus the water ligand is 
not sufficient to drive the heme to a low-spin ferric state 
[39, 55]. On closer inspection of the heme-FeIII environ-
ment between the two enzymes, subtle differences emerge. 
Of significance is a side-chain positional shift of the dis-
tal Asp residue towards the heme in DtpAa (Fig. 3). This 
change, observed in both the 100K composite structure and 
room temperature XFEL structure, permits a H-bonding 
interaction with the  FeIII-heme coordinated water (w1) [39, 
57], an interaction which is absent in DtpA [66], and may 
coincide with the longer w1-FeIII bond-length observed in 
DtpAa (Fig. 3) [39, 57]. In contrast, the distal Arg posi-
tion and H-bonding pattern, as indicated in Fig. 3, remains 
the same between the two A-type structures [39, 55, 57]. 
Therefore, having confidence that the structures represent 
the true stereochemistry of the  FeIII-heme site, the subtle 
side-chain positional change and altered H-bonding water 
pattern for the distal Asp residue between the two A-type 
homologues in S. lividans can be considered significant, 
rather than being an artefact caused by differing oxidation 
states of the enzymes [39, 55, 57].
DtpB
For DtpB the stereochemistry of the distal heme-FeIII envi-
ronment between the composite 100 K and room temperature 
XFEL structures is again identical [35]. Notably both struc-
tures reveal an absence of resident water molecules in the 
distal heme pocket [35]. Thus, in contrast to the ‘wet’ dis-
tal heme pocket found for the A-type enzymes [39, 55], in 
DtpB the pocket is ‘dry’ (Fig. 3) [35]. The heme in DtpB is, 
therefore, pentacoordinate with the  FeIII atom sitting slightly 
out of the porphyrin plane towards the proximal His ligand, 
creating a shorter  FeIII-Nδ-His bond than observed in either 
DtpA or DtpAa (Fig. 3). Thus, the communication between 
the distal pocket Asp/Arg dyad and the heme-FeIII that exists 
through the H-bonded water network in DtpA and DtpAa is 
lost in DtpB [35].
An Asn side chain protrudes into the distal heme envi-
ronment in DtpB, with its amide group occupying the spa-
tial position where in the A-type enzymes a water molecule 
(w2) is located and H-bonded to the distal Asp (Fig. 3) [35, 
39, 57]. It has been suggested that the presence of the Asn 
causes a steric impediment to the formation of a distal water 
network in DtpB [35]. However, as will be discussed further, 
the absence of a w2-Asp interaction has consequences for 
whether Asp or Arg is selected to facilitate proton transfer 
and rate enhancement of Compound I formation [39].
Peroxide access channels
A question that arises from the resting state  FeIII-heme struc-
tures is whether there are any obvious structural features, 
other than the possible presence of the Asn side chain in the 
distal pocket of DtpB, that can account for a ‘dry’ versus 
‘wet’ distal heme site. Surprisingly, an inverse correlation 
of heme accessible surface area (ASA) is found in the order 
DtpB (37.4 Å2) > DtpAa (11.8 Å2) > DtpA (11.2 Å2), clearly 
Fig. 3  Comparison of the validated  FeIII-heme sites in each of the 
DyPs from S. lividans. Water molecules (w) are depicted as small 
cream spheres, hp refers to heme propionate groups and H-bond 
interactions are shown as dashed lines. In DtpAa, the green dashed 
line indicates the additional H-bond to w1, absent in DtpA, which 
result from the positional change of the distal Asp residue as indi-
cated by the arrow. PDB codes used are 6G2W (DtpA); 6TB8 
(DtpAa); 6YRJ (DtpB)
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indicating a more solvent insulated heme in the A-type 
enzymes [35]. Insight into how water or peroxide can enter 
into the heme environment can be investigated using CAVER 
3.0 [67] that can calculate the location of putative access 
channels connecting the heme to the bulk solvent. DtpA has 
two such channels (Fig. 4). One runs from a surface opening 
down into the distal heme pocket, essentially following the 
route of the H-bonded water network (w1 to w5, Fig. 3) and 
the second channel protruding from the γ side of the heme, 
adjacent to the heme propionate-6 group (Fig. 4). This lat-
ter channel is also occupied by water molecules that form a 
continuous H-bonding network from the bulk solvent to the 
Nε atom of the distal Arg residue [55]. DtpAa and DtpB on 
the other hand possess only one surface access channel to 
the heme [35, 39], which is identical in location to the sec-
ond channel in DtpA [55]. It is noticeable that the surface 
entrance diameter for this channel in DtpB is larger than in 
either DtpA or DtpAa (Fig. 4). Thus, based on structural 
analysis, it is not clear why DtpA and DtpAa accommodate 
resident waters in the distal heme site as opposed to DtpB, 
which despite a more solvent accessible heme, favours a 
‘dry’ distal heme site. This begs the question of whether 
it is the ease of solvent egress in DtpB which accounts for 
increased exposure to solvent of the heme site.
Fig. 4  Putative peroxide access channels in the three S. lividans 
DyPs. CAVER 3.0 was used to calculate channels originating from 
the heme-Fe and connecting to a solvent surface opening using the 
following settings: minimum probe radius = 1.2; shell depth = 8; shell 
radius = 7; clustering threshold = 4. For DtpA two predominant path-
ways were identified (blue and green), whereas for DtpAa and DtpB 
only one pathway was identified. The surface representations of the 
respective DyPs indicate where the entry to the channels reside. The 
green channel is common to all three DyPs and enters via the γ heme 
edge, between the two propionate groups. In DtpA the blue channel 
enters into the distal side of the heme. Both channels are lined with 
polar residues and contain H-bonded waters. PDB codes used are 
6G2W (DtpA); 6TB8 (DtpAa); 6YRJ (DtpB)
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An over‑view of the transient kinetics 
of Compound I formation
Understanding the mechanism of formation and chemical 
nature of Compound I has been a focal point of peroxidase 
chemistry for many years [22, 23]. Stopped-flow absorption 
spectroscopy is a commonly used approach to monitor Com-
pound I formation by mixing the resting state ferric enzyme 
with peroxide. The subsequent reaction results in spectral 
changes in the Soret and Q-band region of the electronic 
absorption spectrum that, for many peroxidases, allow Com-
pound I and Compound II to be distinguished and identified 
[22]. Figure 5 provides an illustrative summary of the salient 
kinetic features of Compound I formation reported for each 
of the S. lividans DyPs upon mixing with peroxide using 
stopped-flow absorption spectroscopy [19, 35, 39].
DtpA and DtpB
For DtpA and DtpB the kinetic behaviour follows a single 
spectral transition, resulting in a spectrum with wavelength 
features in the Soret and Q-band region typical for a  FeIV-oxo 
species carrying a porphyrin π-cation radical, i.e. Compound 
I [19, 35]. A linear dependence on the observed pseudo-first 
order rate constants (kobs) with increasing peroxide concen-
tration allows a second-order rate constant for Compound I 
formation (kcmpdI) to be determined (Fig. 5). Notably, DtpA 
possesses a kcmpdI in the region of  107  M−1  s−1 [19], simi-
lar to that of HRP [68, 69], and is thus a highly reactive 
peroxidase. In contrast, DtpB exhibits a kcmpdI in the region 
of  105  M−1  s−1, two-orders of magnitude lower than DtpA 
[35]. Nevertheless, the linear dependence on kobs with 
increasing peroxide concentration for both DtpA and DtpB, 
indicates binding of peroxide to the  FeIII-heme is rate limit-
ing for Compound I formation. Once Compound I is formed 
its life-time in the absence of an exogenous electron donor 
varies between DtpA and DtpB [19, 35]. For DtpA a half-
time  (t1/2) of ~ 2.5 min is reported [19], with EPR spectros-
copy revealing that the electron to fill the porphyrin π-cation 
‘hole’ is acquired through the oxidation of a Tyr residue 
(Tyr374) to generate a  FeIV = O  Tyr• species (i.e. internal 
electron transfer) [55]. By contrast, Compound I in DtpB is 
stable for hours, with EPR spectroscopy reporting a signal 
at g = 2 with a strongly asymmetric line-shape that does not 
change intensity and shows no saturation with microwave 
power, typical of a Compound I species carrying a porphyrin 
π-cation radical [35]. Thus, Compound I is more reactive in 
DtpA than in DtpB.
DtpAa
For DtpAa the kinetics of Compound I formation are sig-
nificantly different from those described above (Fig. 5). The 
spectral transitions observed upon mixing with peroxide 
reveal the presence of an intermediate species, and on fitting 
to a sequential mechanism (i.e. a → b → c) this intermedi-
ate species (b) is shown to have spectral features associated 
with Compound I and the end point spectrum (c) consistent 
with a Compound II species [39]. Thus, unlike in DtpA and 
Fig. 5  A cartoon summary of the stopped-flow reaction kinetics 
reported for the S. lividans DyPs upon reacting with peroxide. For 
each DyP the chemistry that occurs within the heme pocket as deter-
mined from absorbance spectrum changes on mixing with peroxide 
is depicted, along with illustrative plots of kobs versus peroxide con-
centration. The DtpA and DtpAa  FeIII-heme states are illustrated with 
a coordinating water molecule (w1) as corroborated by the X-ray 
crystal structures. For DtpAa, two  FeIII-heme species exist at pH 5, 
species I and II, with species I displaying the same kinetics at pH 7, 
where only one form exists. All kinetic experiments were conducted 
at 25 °C
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DtpB, where a single spectral transition to Compound I is 
observed, in DtpAa, Compound I is formed but decays (in 
the absence of exogenous electron donor) to a Compound II 
species (Fig. 5). Notably, a non-linear dependence of kobs for 
Compound I formation with increasing peroxide concentra-
tion is observed (Fig. 5) [39]. Such a reaction rate profile 
has been suggested to mean that at low peroxide concentra-
tion the rate limit is peroxide binding to the  FeIII-heme as 
evidenced by the steep increase in kobs1 values, whilst at 
higher peroxide concentration a second rate limit takes over 
(Fig. 5) [39]. To further complicate the DtpAa kinetics, both 
stopped-flow spectral analysis and EPR spectroscopy reveal 
the presence of two  FeIII-heme species at pH 5, but only a 
single species at pH 7 (Fig. 5) [39]. These ferric forms have 
been assigned as species I and II, with species I comprising 
45% of the starting ferric DtpAa [39]. The kinetics of Com-
pound I formation reveals species I reacts faster with perox-
ide than species II (Fig. 5), with species I displaying similar 
kobs1 values to those reported at pH 7 [39]. It is important to 
note that the kobs1 values for DtpAa are only a few per sec-
ond, even at peroxide concentrations of 1 mM (Fig. 5) [39], 
compared with hundreds and tens per second with DtpA and 
DtpB, respectively [19]. Thus, DtpAa appears only to have 
limited activity with peroxide. The decay of Compound I 
to Compound II in DtpAa is independent of peroxide con-
centration and has a  kobs2 ~ 0.1  s−1 (Fig. 5) [39]. Whilst not 
reported, the likely source of the electron is from an oxidis-
able amino acid (e.g. Tyr or Trp) within close proximity to 
the heme pocket.
Compound I formation is pH dependent
For both A-type enzymes, Compound I formation has been 
reported to be pH dependent, with kobs values increasing 
between pH 4 and 7 [39]. An ionisation equilibrium con-
stant (pKa) of ~ 4.5 has been determined, which has not been 
attributed to ionisable amino acids, but rather to the pKa 
of the bound peroxide to the  FeIII-heme [39]. The change 
in the electrostatic free energy (ΔGel) for binding peroxide 
to a  FeIII-heme is ~ 34 kJ  mol−1 which equates to a change 
in the pKa of 6 pH units [39]. Thus, a theoretical decrease 
in the pKa of peroxide from 11.5 to 5.5 would be expected 
and in line with the experimental pKa determined [39]. For 
DtpB the pH dependency of Compound I formation has yet 
to be reported.
DtpA possesses a distal heme pocket 
that is finely tuned for rapid reactivity 
with peroxide
Why does DtpA react rapidly and efficiently with peroxide 
to form Compound I whereas DtpAa shows only limited 
reactivity despite the apparent structural similarities? To 
probe further and assist in devising a mechanism of Com-
pound I formation that satisfies the kinetic data and the 
pKa value associated with Compound I formation, studies 
using site-directed mutagenesis and kinetic isotope experi-
ments have been undertaken.
Kinetic isotope effect (KIE)
As Compound I formation is associated with the breaking 
and forming of a O–H bond, then using deuterated per-
oxide may provide information of whether these reaction 
steps in DtpA and DtpAa are rate limiting. For DtpA no 
KIE is observed for Compound I formation [39]. How-
ever, for Compound I formation in DtpAa a KIE of ~ 2 
was determined, with a similar kinetic profile of kobs1 ver-
sus peroxide concentration as observed in water (Fig. 5) 
[39]. No KIE was observed for the decay of Compound 
I to Compound II (kobs2) in DtpAa. These observations 
are entirely consistent with the rate determining step for 
Compound I formation in DtpAa being proton transfer, fol-
lowing the binding of peroxide to the  FeIII-heme, whereas 
for DtpA the absence of a KIE indicates proton transfer is 
faster than peroxide binding [39]. Thus, DtpA has a highly 
tuned distal site to bind peroxide and facilitate proton 
transfer to initiate the heterolytic fission of the O–O bond 
to form Compound I, whereas DtpAa is not optimised [39].
Effect of the distal heme pocket Asp on Compound I 
formation
Substituting the distal Asp residue for an Ala in both DtpA 
and DtpAa and its effect on Compound I kinetics has been 
reported [39]. For DtpAa, the kinetic profile on mixing 
the Asp variant with peroxide was found to be comparable 
with the wild-type (WT) enzyme, i.e. a non-linear depend-
ence on peroxide concentration for Compound I formation 
and rate limiting behaviour for the decay of Compound I 
to Compound II (Fig. 6) [39]. However, at pH 5 only one 
 FeIII-heme form is now detected (Fig. 6). Notably, the  kobs1 
values remain at a few per second, over a wide range of 
peroxide concentrations, indicating that whether the distal 
Asp in DtpAa is present or not, limited peroxide reactivity 
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is retained. This implies that the Asp offers no catalytic 
contribution to Compound I formation.
On the other hand the kinetics of Compound I forma-
tion with the DtpA distal Asp variant differ to that of the 
WT enzyme [39]. Now a two-state transition that passes 
through Compound I to a Compound II species, similar 
to that observed spectroscopically for DtpAa is observed 
(Fig. 6) [39]. In accordance with WT DtpAa and its Asp 
variant, the kobs1 values are now only a few per second com-
pared to hundreds per second for WT DtpA [39]. At pH 5 
a linear dependence of  kobs1 with increasing peroxide con-
centrations is reported, yielding a kcmpdI of 4 ×  103  M−1  s−1 
(Fig. 6). Such a value is analogous to those reported for 
oxidation of water-soluble  FeIII-tetraphenyl-porphyrins with 
peroxide [70], and strongly suggests that unlike in DtpAa, 
the distal Asp in DtpA has a catalytic role. Furthermore, the 
linear dependence of kobs with increasing peroxide concen-
tration indicates that, in this variant, the rate determining 
step is still peroxide binding to the  FeIII-heme, with proton 
transfer faster than peroxide binding [39]. However, at pH 
7 the  kobs1 values become rate limited at high peroxide con-
centration and a KIE of ~ 2 is observed, now indicating that 
proton transfer is rate limiting (Fig. 6). Thus, removal of the 
distal Asp in DtpA disturbs a fine balance between whether 
peroxide binding or proton transfer are rate limiting Com-
pound I formation [39]. Finally, Compound I formation for 
the distal Asp variants in both A-type enzymes is also pH 
dependent, with a pKa of ~ 5.5 determined [39]. This value 
is slightly elevated compared to the WT enzymes but is in 
line with expectations considering removal of a nearby nega-
tive charge.
Mechanism of Compound I formation in DtpA
The kinetic studies strongly advocate DtpA as having a 
finely tuned distal site to activate peroxide and rapidly form 
Fig. 6  A cartoon summary of the stopped-flow reaction kinetics 
reported upon reacting the two distal Asp A-type DyP variants with 
peroxide. For each variant the chemistry that occurs within the heme 
pocket as determined from absorbance spectrum changes is depicted, 
along with illustrative plots of kobs versus peroxide concentration. The 
w1 is coloured grey as in the absence of structural data for these vari-
ants it is not known whether a water coordinates the  FeIII-heme. All 
kinetic experiments were conducted at 25 °C
Fig. 7  The catalytic mechanism of Compound I formation in DtpA based on structural and kinetic data. The  Hα proton of the peroxide is shown 
in red and H-w2+ represents a hydronium ion. For a complete description of the individual steps see main text
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Compound I, whereas DtpAa appears to form Compound 
I in a non-facilitated manner [39]. A catalytic mechanism 
for DtpA that accounts for the reported structural and kinet-
ics studies has been proposed and is depicted in Fig. 7. 
The distal Asp is assigned in an anionic state, comply-
ing with experimental evidence from other DyPs to sug-
gest a pKa <  < 4 [37, 71]. The first step in the mechanism 
is accounted for by the validated  FeIII-heme resting state 
X-ray structure (Fig. 3). However, w1 must be highly labile 
as inferred from the linear dependence of kobs for Compound 
I formation, which in the absence of a KIE indicates that 
peroxide binding is the rate determining step in the overall 
mechanism. To account for the experimentally observed pKa 
in the mechanism, deprotonation of the peroxide to form a 
hydronium ion and Compound 0 is suggested (Fig. 7) [39]. 
Here, w2 as identified in the  FeIII-heme X-ray structure 
H-bonds to the distal Asp (Fig. 3) and can act as a conveni-
ent conduit to move a proton, by first forming a hydronium 
ion and then transiently moving the proton onto the Asp for 
transfer to the −  OHβ prior to heterolysis of the of the O–O 
bond (Fig. 7). It is noted that in the DtpA Asp variant a 
comparable pKa is observed and this is also attributed to the 
formation of a hydronium ion [39]. However, in the absence 
of the Asp this hydronium ion is not optimally configured 
for proton-transfer, but nevertheless at pH 5 proton-trans-
fer remains faster than peroxide binding [39]. Equilibrium 
molecular dynamics and free energy calculations in HRP 
have demonstrated that a water-His unit is energetically 
favoured to move a proton onto the distal OH of the bound 
peroxide rather than direct proton movement involving only 
the distal His [28]. Thus, a similar scenario may be envis-
aged with DtpA. The remaining proton and electron transfer 
steps are rapid (no KIE) and result in Compound I formation 
(Fig. 7).
Based on the mechanism depicted in Fig. 7, a strong 
case can be made for Compound I formation in DtpA to be 
driven by the stereochemistry of the w2-Asp unit. Despite 
DtpAa having the w2-Asp unit (Fig. 3), it is proposed that 
the positional shift identified in the validated X-ray structure 
perturbs the optimal stereochemistry required for a catalytic 
role [28]. Based on the interpretation of the kinetic studies 
for DtpAa it can be argued that the positional change of 
the w2-Asp unit introduces a steric constraint into the distal 
pocket that hinders the rate of peroxide binding, destabilises 
the  FeIII–OH–OH complex and perturbs proton-transfer [28]. 
Thus, DtpA is a highly reactive peroxidase, whereas DtpAa, 
because of the subtle positional change of the w2-Asp unit, 
is not. This explanation highlights that ensuring the X-ray 
structures are determined free of site-specific radiation 
damage, then insights into mechanism can be achieved and 
advanced with confidence.
The observation of this major difference in reactivity 
from otherwise highly similar enzymes with active sites 
that appear at first glance essentially identical, highlights the 
need for kinetic characterisation of peroxidase activity and 
suggests caution in assigning peroxidase activity to DyPs 
purely based on sequence homology or homology model-
ling approaches.
DtpB Compound I structure
The chemical nature of the ferryl species assigned as Com-
pounds I and II in peroxidases has attracted much discus-
sion as to whether they are formulated as an unprotonated 
 FeIV = O or a protonated  FeIV–OH species [18]. The reac-
tivity of these ferryl species is controlled by protonation. 
There is a long experimental history associated with efforts 
to assign the chemical nature of these ferryl species using 
spectroscopy (e.g. EXAFS (Extended X-ray Absorption 
Fine Structure), resonance Raman and Mössbauer), X-ray 
crystallography and more recently neutron crystallography, 
which not only eliminates radiation damage, but also has the 
advantage of being able to observe nuclear density attributed 
to proton positions. A detailed history of the experimental 
efforts to define the nature of ferryl heme has been reviewed 
by Raven and Moody [18]. Regardless of the method used, 
the challenge remains to isolate peroxidases exclusively in 
either the ‘pure’ Compound I or Compound II states [72]. 
These states are often unstable, as evident with DtpA and 
particularly for DtpAa, with mixtures of states in part caus-
ing erroneous interpretation as to the nature of the ferryl 
species. DtpB on the other hand has provided an opportunity 
to obtain an intact structure of a “green” Compound I spe-
cies (i.e. contains a porphyrin π-cation radical) owing to the 
long Compound I life-time.
Green crystals of DtpB could be generated upon addi-
tion of peroxide to ferric crystals (Fig. 8). Both the fixed-
target room temperature SFX approach (zero dose) and a 
100-K composite multi-crystal strategy with in situ monitor-
ing using microspectrophotometry were used to determine 
the structure of this species (Table 2). As noted previously 
with the  FeIII-heme structures, the stereochemistry in the 
distal pocket on comparing the structures from the two 
approaches used were identical within experimental error 
[35]. An electron density feature was observed on the distal 
side of the heme, into which an oxygen atom was readily 
modelled (Fig. 8). Assigning the ferryl species as protonated 
or unprotonated can be implied indirectly by the Fe–O bond 
length, which is often used to determine bond order, i.e. 
single or double bond and thus protonation state. For one 
of the monomers in the asymmetric crystallographic unit 
(total of six) a  FeIV–O bond length of 1.65 Å is reported, 
in both the SFX and 100 K composite structures [35]. This 
bond length falls within the expected range for a  FeIV = O 
species and is line with the most reliable bond lengths (i.e. 
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X-ray structures agree with spectroscopy) determined for 
Compound I species in proteins (1.63 to 1.73 Å) [52–54, 56, 
73–75]. The formation of Compound I in DtpB coincides 
with the formation of a new H-bond network centred around 
the oxo group which accepts H-bonds from the amino group 
of Asn245 and the  Nη1 atom of Arg243 (Fig. 8).
In the other five monomers of the crystallographic asym-
metric unit of DtpB, variation in the Fe–O bond length 
(1.70–1.89  Å) at both room temperature and 100  K is 
reported [35]. Lengthening of the  FeIV–O bond can indicate 
the formation of an  FeIV–OH or  FeIII–OH species [76, 77]. 
For an  FeIV–OH species an Fe–O bond distance determined 
through spectroscopic approaches lies between 1.76 and 
1.82 Å [78, 79], whereas  FeIII–OH is longer > 1.85 Å [77]. 
In peroxidases and globins with histidine-ligated heme, no 
spectroscopic evidence for a  FeIV–OH Compound II species 
has been reported, in accord with the chemistry of peroxi-
dases (i.e. one-electron oxidation of substrates as opposed to 
C–H bond activations as is the case in cytochrome P450s). 
However, the observation of positive nuclear density next 
to the Fe–O bond in the neutron structure of APX Com-
pound II supports a hydroxide species [80]. A Fe–O bond 
distance of 1.88 Å has been determined and the investiga-
tors assign this species as a  FeIV–OH [80]. More recently a 
XFEL study (100 K) with APX Compound II reveals a Fe–O 
bond distance of 1.87 Å [72] and thus confirming the dis-
tance obtained by neutron crystallography [80]. These zero 
dose structural studies suggest that the Compound II species 
generated in APX could be an outlier amongst peroxidases, 
in that an  FeIV–OH species is formed. However, this view 
contrasts to spectroscopy data obtained with EXAFS and 
Mössbauer [81], and more recently NRVS (Nuclear Reso-
nance Vibrational Spectroscopy) [82] where an Fe–O bond 
distance of 1.68 Å for APX Compound II is determined, 
consistent with an unprotonated  FeIV = O species [77]. Thus, 
a disagreement between spectroscopy data and zero dose 
structures exists. For DtpB the heterogeneity in the Fe–O 
bond lengths present in the other asymmetric unit mono-
mers, is at present difficult to explain. X-ray induced reduc-
tion would appear unlikely considering the low absorbed 
dose for the 100 K structure (Table 2) and that the SFX 
approach safeguards against site-specific radiation damage 
occurring. Furthermore, the in situ microspectrophotom-
etry measurements of the crystal after exposure reveal no 
evidence for a mixed valence species [35]. However, the 
increase in bond lengths would suggest a partial onset of 
reduction of the  FeIV = O species. It may be that endogenous 
reductants that depend on local environment which differ 
in each molecule of the asymmetric unit could be causing 
these changes. Further investigation through the acquisition 
of dose series data (i.e. by feeding electrons into the sys-
tem via radiolysis) could shed light into the heterogeneity 
of Fe–O bond lengths observed amongst the monomers in 
the DtpB crystallographic asymmetric unit.
The distal Arg facilitates O–O heterolysis 
in DtpB
The ‘dry’ distal heme site identified in  FeIII-heme DtpB 
reveals that the water-mediated Asp mechanism utilised 
for Compound I formation in DtpA cannot occur in this 
B-type DyP [39]. However, Compound I in DtpB does 
form rapidly. No KIE is observed (Lučić unpublished data) 
and thus peroxide binding is the rate determining step with 
proton transfer being faster than the binding of peroxide. 
Fig. 8  Top panel: Microcrystals (~ 10 μm) of DtpB in the  FeIII-heme 
state (brown) and in the  FeIV-heme state (green) following addition 
of  H2O2. Bottom panel: Heme site of DtpB (chain A) determined 
by SFX at room temperature following addition of  H2O2 to the 
 FeIII-heme microcrystals [35]. The 2Fo-Fc electron density map (blue) 
contoured at 1.4 σ and the Fo-Fc omit map (green) contoured at ± 10 
σ, calculated after refinement, omitting the oxygen atom (red sphere). 
H-bond interactions involving the  FeIV = O are indicated in dashed 
lines. PDB code used 6YRD
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Furthermore, the kcmpdI is significantly higher than for a non-
facilitated Compound I formation as observed for DtpAa 
and  FeIII-tetraphenyl-porphyrins, so even in the absence of 
a water-Asp unit a catalytic role for either the Asp or Arg 
would be expected.
Substitution of the distal Asp and Arg residues with an 
Ala has helped to elucidate their roles in Compound I forma-
tion in DtpB [35]. For the Asp variant, the kinetic and spec-
tral properties of Compound I formation are identical to WT 
DtpB. However, in the Arg variant, Compound I forms (over 
many minutes) and decays back to the  FeIII-heme species. 
Thus, removal of the distal Arg slows Compound I formation 
and renders it unstable [35]. These data have been taken to 
indicate that in DtpB Arg is selected to facilitate Compound 
I formation. Interestingly, the presence of a distal pocket 
Asn is noted in two other DyPs for which reports suggest 
the formation of Compound I is Arg dependent [33, 83]. 
Thus, based on the structural and kinetic studies with DtpB, 
a combination of a ‘dry’ site, and the presence of an Asn in 
the distal pocket could be part of the structural criteria that 
selects Arg for proton movement on peroxide binding to the 
 FeIII-heme [35].
Can an Arg facilitate general acid/base chemistry? Exam-
ples of Arg acting as a catalytic base have been reported 
in enzymes including metalloenzymes [84], despite the 
guanidinium group having a pKa of 13.8 [85], and thus pro-
tonated at neutral pH. Furthermore, several neutron struc-
tures have provided evidence for the existence of guanidine 
(neutral) side chains [86–88], including APX when bound 
to its substrate ascorbic acid [89]. A recent report has high-
lighted the need for an Arg to boost peroxidase activity in 
artificial metalloenzyme containing a manganese porphyrin 
that possesses dye-decolorizing activity [90]. An excellent 
review by Schlippe and Hedstrom [91], surveys enzymes 
which by implication use Arg as an acid/base catalyst. A 
key factor to consider is what fraction of an Arg must be 
deprotonated for effective general base catalysis to occur. 
Providing this fraction is kinetically competent it will be 
sufficient to drive catalysis. Two further considerations are 
of note. The first, is that Arg residues that have been identi-
fied as potential bases are H-bonded to carboxylate groups 
and second, they can link, through H bonding networks to 
the bulk solvent [86–88, 91]. The distal Arg in DtpB satisfies 
both these criteria; it is H-bonded to the carboxylates of the 
heme propionate-7 group and its  Nε atom is H-bonded to a 
water which is part of the H-bonded water network that leads 
to the surface opening at the γ face of the heme, as identi-
fied using CAVER (Fig. 4). It has been suggested that the 
carboxylates of the Arg-carboxylate motif catalyses proton 
exchange, which is rapid and efficient owing to the commu-
nication with bulk solvent [86–88, 91]. This would ensure 
that the active deprotonated non-planar (neutral) form is in 
rapid equilibrium with the inactive planar (charged) form, 
so at any one time a fraction of the active enzyme is present. 
Taking these factors into account along with the structural 
and kinetic data a mechanism for Compound I formation for 
DtpB can be proposed (Fig. 9).
Consequences of a ‘dry’ distal pocket
The ‘dry’ distal heme pocket identified in  FeIII-heme DtpB 
remains in the Compound I structure. This indicates that 
the water molecule coproduced on Compound I formation 
is released from the distal pocket, emphasising the impor-
tance of the ease of egress allowed by solvent exposure of 
the heme site. It has been proposed that the release or reten-
tion of the coproduced water molecule upon Compound I 
formation may influence whether a two-electron reduction 
of Compound I occurs (a ‘dry’ site; water released) such 
as in catalases or two one-electron equivalent processes (a 
‘wet site; water retained) resulting first in the Compound 
II intermediate and then the ferric resting state, as in per-
oxidases [92]. This concept of a redox pathway switching 
mechanism arose in the early 2000’s when more X-ray struc-
tures of peroxidases and catalases were becoming available. 
However, as commented on above, site-specific radiation 
damage is now known to be a confounding factor in these 
earlier structures. Thus, despite initial insights into the pres-
ence or absence of heme distal pocket water molecules that 
underpins this redox switching theory, an air of caution 
should remain as in DyPs, distal pocket waters can move 
and disappear upon a change of redox state caused by radia-
tion damage [45, 49]. Nevertheless, the ‘dry’ versus ‘wet’ 
theory is compelling, but at the same time has yet to be 
unequivocally proven. Structural evidence to support and 
test the theory has been lacking, but the DtpB Compound I 
Fig. 9  The catalytic mechanism of Compound I formation in DtpB 
based on structural and kinetic data. See main text for a discussion of 
the individual steps
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structure provides a starting point to test whether a ‘dry’ site 
does indeed lead to simultaneous two-electron reduction to 
the ferric state.
Finally, a ‘dry’ distal site in DtpB may have consequences 
for reactivity. First it has been recognised that the polar-
ity of the distal heme pocket promotes charge separation, 
as is required for heterolytic cleavage of the O–O bond, 
whereas nonpolar environments promote homolytic cleav-
age. In myoglobin, ~ 30% of peroxide bond-breaking occurs 
via homolytic cleavage [93]. The absence of water in the 
distal pocket in DtpB will certainly affect the distal pocket 
polarity. However, on reaction with peroxide an electronic 
absorption spectrum consistent with a Compound I species 
forms as expected for heterolytic cleavage, with no detection 
of a Compound II spectrum [35], which would be expected 
if homolytic cleavage had occurred. Once Compound I is 
formed in DtpB, it is highly stable, and thus unreactive. It is 
known that preparing Compound I-like derivatives in ferric 
porphyrin complexes in non-aqueous solvents gives rise to 
very stable ferryl species in the absence of an electron donor 
[94]. However, by increasing the polarity through addition 
of water, the ferryl species are markedly destabilised sug-
gesting that a factor for Compound I stability not only in 
these DyPs but also peroxidases in general may be linked 




The combination of determining redox state validated 
X-ray structures coupled with stopped-flow kinetics and 
site-directed mutagenesis studies has proven key to under-
standing the mechanistic subtleties of Compound I forma-
tion in this set of DyPs. However, only the structures and 
mechanisms associated with the formation of the first fer-
ryl intermediate species, Compound I, have to date been 
reported. No structural studies on a DyP Compound II spe-
cies are available and approaches to address this would be a 
next step. It is noted that cryo-trapping of ‘pure’ Compound 
II in APX and CcP has been possible [72, 80], and such 
an approach may be amenable in this set of DyPs. How-
ever, whilst obtaining ‘static’ structures of ferryl species are 
clearly not without challenges, a grand challenge would be to 
capture the intact structures of the peroxidatic cycle in ‘real-
time’. In this respect the on-going developments in room 
temperature time resolved X-ray crystallography open an 
exciting area to exploit the visualisation of structural inter-
mediates in reaction cycles [95, 96]. The initial knowledge of 
the solution state kinetics for this set of DyPs form the basis 
for planning time-resolved crystallography experiments. For 
example, on mixing peroxide with DtpAa, Compound I and 
Compound II species are sequentially formed (Fig. 5), with 
their life-times amenable to time-resolved crystallography 
approaches. It is, therefore, conceivable that mixing peroxide 
with DtpAa microcrystals will allow time-resolved struc-
tural characterisation of the peroxidatic pathway. Both low-
dose synchrotron and XFEL experiments can achieve this, 
with a key requirement being spectroscopic validation of a 
particular intermediate state occurring at a particular time 
point, which may well be different to the reaction time point 
observed in stopped-flow solution kinetics. However, recent 
methodological developments in this area such as the use of 
X-ray emission spectroscopy (XES) arising from the same 
X-ray pulse as used for diffraction data collection, will allow 
for the validation of structures corresponding to particular 
time points for the reaction in the crystal to be determined. 
Mixing approaches recently developed include microfluidic 
[97, 98] or larger scale turbulent mixing [99] as well as drop-
on-drop mixing either in fixed targets [100] or on a moving 
tape [101]. Taking advantage of these methods would also 
give scope for DtpA and DtpB to be studied by first generat-
ing Compound I in situ followed by injection into the system 
of an electron donor or by controlled use of the X-ray beam.
Involvement of protons
The movement of electrons in metalloenzymes is often 
accompanied by movement of protons. As indicated sev-
eral times in this review, proton movement in the peroxi-
dase cycle is important and centrally involved in mechanism. 
Whilst a major focus has been to ensure that redox states of 
crystal structures are validated, questions as to the protona-
tion state of key residues around the distal heme pocket at 
different stages of the catalytic cycle remain. Protonation 
may be directly observed by neutron crystallography for 
stable or cryo-trapped intermediates, although neutron dif-
fraction experiments remain challenging [102]. However, 
neutron experiments have been successfully used to probe 
the protonation state of cryo-trapped ferryl states in CcP 
and APX [74, 80], as well as their distal pocket residues, 
and more recently to visualise the proton transfer pathways 
in APX bound to its substrate ascorbate [89]. Very recently, 
atomic resolution XFEL structures from large crystals at 
100 K have been produced of CcP using serial femtosec-
ond rotation crystallography (SF-ROX) with the ultrahigh 
resolution allowing protonation states to be assessed [72]. 
Application of this approach to DyPs could be very informa-
tive, particularly as the S. lividans DyP macro-crystals will 
diffract to < 1.2 Å using a synchrotron X-ray source.
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